Memory Disorders - Drug therapy
Research News and Information

Monday, November 23, 2009

Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report.

30 Aug 2009 Cognitive deficits are commonly associated with maintenance electroconvulsive therapy (ECT). Treatment of these cognitive deficits is important but difficult. Cholinergic pathways are involved in these side effects, and donepezil, a cholinesterase ... Read more...

The APP-interacting protein FE65 is required for hippocampus-dependent learning and long-term potentiation.

25 Aug 2009 FE65 is expressed predominantly in the brain and interacts with the C-terminal domain of beta-amyloid precursor protein (APP). We examined hippocampus-dependent memory and in vivo long-term potentiation (LTP) at the CA1 synapses with ... Read more...

Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling.

31 Jul 2009 Cognitive impairment is one of the most important negative consequences associated with cannabis consumption. We found that CB1 cannabinoid receptor (CB1R) activation transiently modulated the mammalian target of rapamycin (mTOR)/p70S6K pathway and ... Read more...

Latest indexed articles for 'Memory Disorders - Drug therapy'

These are the very latest articles for this heading:

• Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report. 30 Aug 2009
• The APP-interacting protein FE65 is required for hippocampus-dependent learning and long-term potentiation. 25 Aug 2009
• Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. 31 Jul 2009
• Chorea associated with gabapentin use in an elderly man. 30 Jul 2009
• Grape juice, berries, and walnuts affect brain aging and behavior. 27 Jul 2009
• Muscarinic receptor 1 agonist activity of novel N-aryl carboxamide substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models. 19 Jun 2009
• Improved effect of Pycnogenol on impaired spatial memory function in partial androgen deficiency rat model. 30 May 2009
• Pharmacological intervention of hippocampal CA3 NMDA receptors impairs acquisition and long-term memory retrieval of spatial pattern completion task. 21 May 2009
• Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease. 19 May 2009
• Effects of clioquinol on memory impairment and the neurochemical modifications induced by scrapie infection in golden hamsters. 18 May 2009
• Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. 18 May 2009
• The ameliorating effects of NMDA receptor agonists on histamine H1 antagonist-induced memory and hippocampal theta disruptions are prevented by the H3 receptor agonist in rats. 18 May 2009
• Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase. 6 May 2009
• Fluoxetine attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. 5 May 2009
• Inhibitory effect of Poncirus trifoliate on acetylcholinesterase and attenuating activity against trimethyltin-induced learning and memory impairment. 5 May 2009
• Timosaponin AIII, a saponin isolated from Anemarrhena asphodeloides, ameliorates learning and memory deficits in mice. 3 May 2009
• Isradipine antagonizes hypobaric hypoxia induced CA1 damage and memory impairment: Complementary roles of L-type calcium channel and NMDA receptors. 29 Apr 2009
• Nefiracetam activation of CaM kinase II and protein kinase C mediated by NMDA and metabotropic glutamate receptors in olfactory bulbectomized mice. 25 Apr 2009
• Verapamil enhances acute stress or glucocorticoid-induced deficits in retrieval of long-term memory in rats. 22 Apr 2009
• Selection of nutrients for prevention or amelioration of lead-induced learning and memory impairment in rats. 6 Apr 2009

See a longer list of these articles.

Technical information about 'Memory Disorders'

Definition: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.

Descriptor UI: D008569

Alternative terms: Memory Disorders; Memory Disorder; Retention Disorders, Cognitive; Cognitive Retention Disorder; Cognitive Retention Disorders; Retention Disorder, Cognitive; Memory Loss; Memory Losses; Memory Disorder, Semantic; Memory Disorders, Semantic; Semantic Memory Disorders; Semantic Memory Disorder; Memory Disorder, Spatial; Memory Disorders, Spatial; Spatial Memory Disorders; Spatial Memory Disorder; Age-Related Memory Disorders; Age Related Memory Disorders; Age-Related Memory Disorder; Memory Disorder, Age-Related; Memory Disorders, Age-Related; Memory Disorders, Age Related; Memory Deficits; Deficit, Memory; Deficits, Memory; Memory Deficit;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; diagnosis; diet therapy; drug therapy; economics; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; rehabilitation; surgery; therapy; urine; ultrasonography; virology;

Tree Number: C10.597.606.525; C23.888.592.604.529; F01.700.625;

History Note: 1969